Pharmacokinetics and dosing regimens of direct oral anticoagulants in morbidly obese patients: an updated literature review

Y Zhao, M Guo, D Li, W Xu, C Pan… - Clinical and Applied …, 2023 - journals.sagepub.com
Data on the impact of morbid obesity (body mass index [BMI]≥ 40 kg/m2) on the
pharmacokinetics (PK), pharmacodynamics (PD) of direct oral anticoagulants (DOACs) are …

Safety and efficacy of direct oral anticoagulants in comparison to warfarin in obese patients with atrial fibrillation: A systematic review and meta‐analysis

A Adelkhanova, PR Oli, DB Shrestha… - Health Science …, 2024 - Wiley Online Library
Abstract Background and Aim Obesity affects nearly 650 million adults worldwide, and the
prevalence is steadily rising. This condition has significant adverse effects on cardiovascular …

[HTML][HTML] The safety and efficacy of nonvitamin K antagonist oral anticoagulants in morbidly obese patients with atrial fibrillation: a meta-analysis

S Elfar, SA Mahmoud, S Hamdi, AA Emad… - BMC Cardiovascular …, 2024 - Springer
Background and aim Atrial fibrillation (AF) is the most frequently observed cardiac
arrhythmia in clinical settings. Obesity can influence the efficacy of the treatment …

Development of Bovine Embryo Culture System for Maintaining Genetic Identity of Embryos

GK Deb, MFH Miraz… - Asian Journal of …, 2024 - article.publish4promo.com
Cumulus-oocyte complexes (COCs) recovered during an ovum pick-up (OPU) session from
a cow is low (1 to 15 COCs). Moreover, mixing of two or more cows COCs to increase total …

[PDF][PDF] Expert Opinion on the Usage of Novel Oral Anticoagulants in Clinical Conditions in Indian Settings

S Manjula, M Krishna Kumar - Asian J. Res. Cardio. Dis, 2024 - article.publish4promo.com
Objective: The current survey-based study aims to better understand expert opinion on the
most commonly prescribed anticoagulants in clinical practice, with a special focus on the …

Разлике у активности фактора коагулационе каскаде и концентрацијама фибриногена и Д-димера, код пацијената са плућном тромбоемболијом на терапији …

J Џудовић - Универзитет одбране, 2023 - nardus.mpn.gov.rs
Терапија директним оралним антикоагулансима (ДОАК) је према савременим
водичима препоручена за лечење пацијената са плућном тромбоемболијом (ПТЕ) …

[PDF][PDF] UNIVERZITET ODBRANE MINISTARSTVO ODBRANE REPUBLIKE SRBIJE MEDICINSKI FAKULTET VOJNOMEDICINSKE AKADEMIJE

JM Džudović - mfvma.mod.gov.rs
SAŽETAK UVOD: Antikoagulantna terapija direktnim oralnim antikoagulansima (DOAK) je
prema savremenim vodičima apsolutna preporuka za nastavak lečenje pacijenata sa …